Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Waystar Holding Corp (WAY) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Health Information Services
$39.98
-0.51 (-1.25%)10 Quality Stocks Worth Considering Now
Researching Waystar (WAY) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on WAY and similar high-potential opportunities.
Based on our analysis of 13 Wall Street analysts, WAY has a bullish consensus with a median price target of $49.00 (ranging from $45.00 to $51.00). The overall analyst rating is Strong Buy (9.3/10). Currently trading at $39.98, the median forecast implies a 22.6% upside. This outlook is supported by 12 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Glen Santangelo at Jefferies, projecting a 27.6% upside. Conversely, the most conservative target is provided by Stephanie Davis at Barclays, suggesting a 12.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for WAY.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
May 8, 2025 | Truist Securities | Jailendra Singh | Buy | Maintains | $50.00 |
May 1, 2025 | Canaccord Genuity | Richard Close | Buy | Maintains | $47.00 |
Apr 14, 2025 | Barclays | Stephanie Davis | Overweight | Maintains | $45.00 |
Mar 14, 2025 | Truist Securities | Jailendra Singh | Buy | Initiates | $45.00 |
Feb 24, 2025 | Canaccord Genuity | Richard Close | Buy | Maintains | $50.00 |
Feb 19, 2025 | Barclays | Stephanie Davis | Overweight | Maintains | $50.00 |
Feb 19, 2025 | Goldman Sachs | Adam Hotchkiss | Buy | Maintains | $52.00 |
Feb 11, 2025 | Jefferies | Glen Santangelo | Buy | Initiates | $51.00 |
Jan 14, 2025 | Goldman Sachs | Adam Hotchkiss | Buy | Maintains | $44.00 |
Jan 6, 2025 | B of A Securities | Allen Lutz | Buy | Maintains | $43.00 |
Jan 3, 2025 | Canaccord Genuity | Richard Close | Buy | Maintains | $42.00 |
Nov 22, 2024 | Raymond James | Brian Peterson | Strong Buy | Upgrade | $40.00 |
Nov 7, 2024 | Goldman Sachs | Adam Hotchkiss | Buy | Maintains | $39.00 |
Nov 7, 2024 | RBC Capital | Sean Dodge | Outperform | Maintains | $34.00 |
Nov 7, 2024 | Evercore ISI Group | Elizabeth Anderson | Outperform | Maintains | $36.00 |
Nov 7, 2024 | Canaccord Genuity | Richard Close | Buy | Maintains | $36.00 |
Oct 14, 2024 | B of A Securities | Allen Lutz | Buy | Maintains | $32.00 |
Oct 8, 2024 | Evercore ISI Group | Elizabeth Anderson | Outperform | Maintains | $32.00 |
Sep 6, 2024 | RBC Capital | Sean Dodge | Outperform | Maintains | $31.00 |
Aug 19, 2024 | JP Morgan | Anne Samuel | Overweight | Maintains | $27.00 |
The following stocks are similar to Waystar based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Waystar Holding Corp has a market capitalization of $6.92B with a P/E ratio of 333.4x. The company generates $975.19M in trailing twelve-month revenue with a 2.7% profit margin.
Revenue growth is +14.1% quarter-over-quarter, while maintaining an operating margin of +25.4% and return on equity of +1.0%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Provides revenue cycle management solutions for healthcare.
Waystar generates revenue by offering cloud-based software solutions that optimize billing, collections, and payment processes for healthcare organizations. Their platform utilizes advanced technologies like artificial intelligence and data analytics to enhance the financial performance of healthcare providers.
The company serves a diverse clientele ranging from small clinics to large hospital systems, significantly reducing administrative burdens and enabling healthcare professionals to concentrate on patient care. Headquartered in Louisville, Kentucky, Waystar is recognized for its innovative approach to improving the efficiency and sustainability of financial operations in the healthcare sector.
Healthcare
Health Information Services
1,500
Mr. Matthew J. Hawkins
United States
2024
Waystar (Nasdaq: WAY) was named Best Overall Healthcare Payments Solutions Provider by MedTech Breakthrough, highlighting its software's value in reducing administrative waste in healthcare.
Waystar's recognition as a top healthcare payments provider highlights its competitive edge and potential for growth in a market addressing significant administrative waste.
Waystar Holding Corp. will hold its Q1 2025 earnings conference call on April 30, 2025, at 4:30 PM ET, featuring key executives and financial analysts from major firms.
The Waystar Q1 2025 earnings call signals upcoming financial performance insights, critical for assessing company health and stock valuation, influencing investment decisions.
Waystar Holding Corp. reported Q1 2025 revenue growth of 14% year-over-year, net income of $29.3M, and adjusted EBITDA margin of 42%. It raised revenue and EBITDA guidance for 2025.
Waystar's strong Q1 revenue growth and net income, alongside raised guidance for 2025, signal robust financial health and potential for future profitability, positively influencing investor sentiment.
Waystar (Nasdaq: WAY) will have CEO Matt Hawkins and CFO Steve Oreskovich speaking at two investor conferences, as announced on April 30, 2025.
Leadership appearances at investor conferences can signal company transparency and growth prospects, potentially influencing stock performance and investor confidence in Waystar.
Waystar (Nasdaq: WAY) is hosting an Innovation Showcase today, highlighting its Altitude AIโข expansion that speeds up claim processes from days to minutes, improving efficiency for providers.
Waystar's Altitude AIโข enhancement significantly speeds up claim processes, suggesting improved operational efficiency and potential revenue growth, which can boost investor confidence and stock value.
MOGO, MX, WAY, FLNT, and FOXA have been designated as Zacks Rank #1 (Strong Buy) as of April 23, 2025.
Stocks added to the Zacks Rank #1 list indicate strong potential for price appreciation, suggesting favorable conditions for short-term gains and increased investor interest.
Based on our analysis of 13 Wall Street analysts, Waystar Holding Corp (WAY) has a median price target of $49.00. The highest price target is $51.00 and the lowest is $45.00.
According to current analyst ratings, WAY has 12 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $39.98. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict WAY stock could reach $49.00 in the next 12 months. This represents a 22.6% increase from the current price of $39.98. Please note that this is a projection by Wall Street analysts and not a guarantee.
Waystar generates revenue by offering cloud-based software solutions that optimize billing, collections, and payment processes for healthcare organizations. Their platform utilizes advanced technologies like artificial intelligence and data analytics to enhance the financial performance of healthcare providers.
The highest price target for WAY is $51.00 from Glen Santangelo at Jefferies, which represents a 27.6% increase from the current price of $39.98.
The lowest price target for WAY is $45.00 from Stephanie Davis at Barclays, which represents a 12.6% increase from the current price of $39.98.
The overall analyst consensus for WAY is bullish. Out of 13 Wall Street analysts, 12 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $49.00.
Stock price projections, including those for Waystar Holding Corp, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.